26 Jul
2020

Nobel laureate’s CAFC loss; IBM and Samsung do patent deal; Big value in narrowed claims; Major Fujitsu chip IP transfer; Apple under attack in China; plus much more

Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week

MONDAY 20th July

Recent CNIPA invalidity decisions have handed setbacks to both sides in a Chinese patent battle over micro-electromechanical system microphone technology. Read more here

After success of early-stage covid-19 vaccine trial, Oxford University’s coronavirus IP licensing policy explained. Read more here

IPValue subsidiary Pannova Semic has agreed to license a worldwide portfolio of 500 semiconductor processing patents formerly owned by Panasonic to a sub-set of RPX members. Read more here

TUESDAY 21st July

A deal between Huawei and a US NPE in the media codec space indicates that the Chinese company is continuing to look to overseas partners to facilitate its patent monetisation efforts. Read more here

German data on partially invalidated patents and subsequent renewal rates provides clear evidence of the value that can exist in grants with narrowed claims. Read more here

Canadian bank announces launch of multi-million-dollar financing package for IP-rich businesses, while Ontario government unveils new IP action plan. Read more here

WEDNESDAY 22nd July

A major reorganisation at Fujitsu sees the Japanese company transfer a significant batch of chip patents to a business set to be acquired by ON Semiconductor. Read more here

The current coronavirus crisis has affected M&A in the med-tech sector, but older trends will shape longer-term deal-making developments. Read more here

Industry organisation MC-IF, whose members include Apple, Ericsson and Oppo, invites patent owners to take part in creating a new VVC pool. Read more here

THURSDAY 23rd July

Silicon Valley-based Velodyne Lidar announced a long-term patent deal with China’s Hesai Photonics Technology this week. Read more here

Nobel laureate Dr Tasuku Honjo and his commercial partners last week lost a CAFC appeal in a dispute over the ownership of six patents covering revolutionary cancer immunotherapy methods. Read more here

Recent big-ticket deals in the biotech sector emphasise just how important it is to get IP valuations right. Read more here

FRIDAY 24th July

A recent ruling by the Supreme People’s Court confirms that France Brevets is among the patent owners currently targeting Apple in China. Read more here

Ant Group’s patent filings have exploded since the second half of 2019 and, although it is difficult to discern the quality of the assets concerned, the portfolio is in capable hands. Read more here

IBM’s recent deal activity has continued with USPTO records revealing a new assignment to Samsung made earlier this month. Read more here

SATURDAY 25th July

As Canada gets its IP act together, other countries would do well to follow suit - especially at a time of growing economic uncertainty. Read more here

IAM has made all its content relating to the covid-19 pandemic free-to-view. You can access our back catalogue via this link.

Book your place at IPBC Connect today

Joff Wild

Author | Editor-in-chief

[email protected]

Joff Wild